(HealthDay)—Oral contraceptive use is associated with a reduced risk for ovarian cancer for BRCA mutation carriers, according to a study published in the July issue of the American Journal of Obstetrics & Gynecology.
Jul 7, 2021
0
1
Preclinical trials of a new radiopharmaceutical to treat ovarian cancer have produced successful results, dramatically limiting tumor growth and decreasing tumor mass. Designed specifically for ovarian cancers that are resistant ...
Jun 11, 2021
0
2
An odor-based test that sniffs out vapors emanating from blood samples was able to distinguish between benign and pancreatic and ovarian cancer cells with up to 95 percent accuracy, according to a new study from researchers ...
Jun 1, 2021
0
1
Several Phase II clinical trials conducted by researchers from The University of Texas MD Anderson Cancer Center show promising results for patients with melanoma, breast cancer, HER2-positive tumors and ovarian cancer. The ...
May 24, 2021
0
1
A more than 30-year study into the long-term impact on mortality rates of screening for ovarian cancer has found that the cancer can be detected early and before women develop symptoms, but it does not translate to saving ...
May 13, 2021
0
2
In a collaborative report published today in Cell, scientists from Sydney and New York describe the critical worldwide need to improve the diversity of cells used in medical research. Currently, 95% of all human cell lines ...
May 13, 2021
0
3
A study published today in Nature Communications shows that the drug rucaparib has been effective in treating certain types of ovarian cancers if used early in treatment, after a diagnosis, and before the cancer cells build ...
May 4, 2021
0
32
(HealthDay)—For vulnerable older patients with ovarian cancer, single-agent carboplatin is less active, with worse survival, than combination carboplatin-paclitaxel regimens, according to a study published online April ...
Apr 27, 2021
0
2
A new study from University of Kentucky Markey Cancer researchers shows that Artemisia annua, a plant that has been traditionally used for its anti-malaria components, shows promise in treating ovarian cancer.
Apr 26, 2021
0
3
Modified immune cells that ruthlessly kill cancerous tumors may prove a game-changer for people living with late-stage cancer.
Apr 15, 2021
0
262
